Trial · NCT03163446
Results by group80
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 80
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Incidence of Adverse Events [Safety and Tolerability] | CF-301 | TEAE through Day 7 | 48 | Participants | |
| Incidence of Adverse Events [Safety and Tolerability] | Placebo | TEAE through Day 7 | 30 | Participants | |
| Incidence of Adverse Events [Safety and Tolerability] | CF-301 | TEAE through TOC | 64 | Participants | |
| Incidence of Adverse Events [Safety and Tolerability] | Placebo | TEAE through TOC | 40 | Participants | |
| Incidence of Adverse Events [Safety and Tolerability] | CF-301 | TEAE through Day 180 | 67 | Participants | |
| Incidence of Adverse Events [Safety and Tolerability] | Placebo | TEAE through Day 180 | 40 | Participants | |
| Clinical Outcome at Day 14 | CF-301 | Responder (Improvement/Response) | 50 | Participants | |
| Clinical Outcome at Day 14 | Placebo | Responder (Improvement/Response) | 27 | Participants | |
| Clinical Outcome at Day 14 | CF-301 | Non-response | 18 | Participants | |
| Clinical Outcome at Day 14 | Placebo | Non-response | 13 | Participants | |
| Clinical Outcome at Day 14 | CF-301 | Indeterminate | 3 | Participants | |
| Clinical Outcome at Day 14 | Placebo | Indeterminate | 5 | Participants | |
| CF-301 Maximum Plasma Concentration (Cmax) | CF-301 | 1450.33 | Standard Deviation 636.83 | ng/mL | |
| CF-301 Area Under the Curve (AUC 0-t) | CF-301 | 5667.42 | Standard Deviation 3032.03 | ng*hr/mL | |
| Clinical Outcome at Day 7 | CF-301 | Responder (Improvement/Response) | 51 | Participants | |
| Clinical Outcome at Day 7 | Placebo | Responder (Improvement/Response) | 31 | Participants | |
| Clinical Outcome at Day 7 | CF-301 | Non-response | 17 | Participants | |
| Clinical Outcome at Day 7 | Placebo | Non-response | 11 | Participants | |
| Clinical Outcome at Day 7 | CF-301 | Indeterminate | 3 | Participants | |
| Clinical Outcome at Day 7 | Placebo | Indeterminate | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03163446/results